The use of complementary alternative medicines in advanced cancer patients followed at home

被引:4
|
作者
Mercadante, Sebastiano [1 ]
Bellavia, Giuseppe [2 ]
Lo Cascio, Alessio [1 ]
Dabbene, Marcella [1 ]
di Silvestre, Grazia [3 ]
Casuccio, Alessandra [4 ]
机构
[1] La Maddalena Canc Ctr, Main Reg Ctr Canc Pain & Support Palliat Care, Palermo, Italy
[2] SAMOT, Reg Home Care Program, Palermo, Italy
[3] ASP 6, Operat Palliat Care Unit, Palermo, Italy
[4] Univ Palermo, Chair Hyg, Palermo, Italy
关键词
Advanced cancer; Palliative care; Home care; Complementary alternative medicine; PREVALENCE; CARE;
D O I
10.1007/s00520-021-06580-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives To assess the use of complementary alternative medicines (CAM) in advanced cancer patients followed at home. Methods A consecutive sample of advanced cancer patients admitted to a home palliative care program was invited to participate in the study in a period of two months. Demographic characteristics, religious belief, education level, diagnosis, and socio-economic condition were recorded. Patients were asked about the use of CAM, considered to be a health-related treatment practiced outside the established health services. Information about CAM indications and those who prescribed or suggested CAM were also collected. Results Two hundred and eighty-three advanced cancer patients followed at home were surveyed. Twelve patients (4.2%) were receiving CAM. The indication and type of CAM were variable, as well as the costs. Given the low number of patients taking CAM, no further analysis was performed. Conclusion A limited number of advanced cancer patients followed at home were using CAM. Further multicenter studies with a larger sample should be performed to provide information about such therapies, also including eventual benefits.
引用
收藏
页码:2003 / 2008
页数:6
相关论文
共 50 条
  • [1] The use of complementary alternative medicines in advanced cancer patients followed at home
    Sebastiano Mercadante
    Giuseppe Bellavia
    Alessio Lo Cascio
    Marcella Dabbene
    Grazia di Silvestre
    Alessandra Casuccio
    Supportive Care in Cancer, 2022, 30 : 2003 - 2008
  • [2] Patients use complementary and alternative medicines
    Kerr, C
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (18) : 2781 - 2781
  • [3] Patients use complementary and alternative medicines
    Kerr, C
    LANCET ONCOLOGY, 2005, 6 (11): : 832 - 832
  • [4] The use of complementary and alternative medicines among patients with locally advanced breast cancer - A descriptive study
    Helyer L.K.
    Chin S.
    Chui B.K.
    Fitzgerald B.
    Verma S.
    Rakovitch E.
    Dranitsaris G.
    Clemons M.
    BMC Cancer, 6 (1)
  • [5] Complementary and alternative medicines in cancer patients
    Bosacki, Claire
    Vallard, Alexis
    Gras, Mathilde
    Daguenet, Elisabeth
    Morisson, Stephanie
    Mery, Benoite
    Jmour, Omar
    Guy, Jean-Baptiste
    Magne, Nicolas
    BULLETIN DU CANCER, 2019, 106 (05) : 479 - 491
  • [6] The use of complementary and alternative therapy by advanced cancer patients receiving palliative care at home
    Pietrzynski, Lukasz
    Pysz-Waberski, Dariusz
    Ska, Tatiana Pietrzyr
    Kliber, Michal
    Gisterek, Iwona
    PALLIATIVE MEDICINE IN PRACTICE, 2022, 16 (02): : 108 - 116
  • [7] Use of complementary and alternative medicines by ambulatory patients
    Rhee, SM
    Garg, VK
    Hershey, CO
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) : 1004 - 1009
  • [8] Complementary and alternative medicines taken by cancer patients
    Simon, L.
    Prebay, D.
    Beretz, A.
    Bagot, J-L
    Lobstein, A.
    Rubinstein, I.
    Schraub, S.
    BULLETIN DU CANCER, 2007, 94 (05) : 483 - 488
  • [9] Pattern of drug use by advanced cancer patients followed at home
    Mercadante, S
    Fulfaro, F
    Casuccio, A
    JOURNAL OF PALLIATIVE CARE, 2001, 17 (01) : 37 - 40
  • [10] Risk evaluation of the use of complementary and alternative medicines in cancer
    Renet, S.
    de Chevigny, A.
    Hoacoglu, S.
    Belkarfa, A-L
    Jardin-Szucs, M.
    Bezie, Y.
    Jouveshomme, S.
    ANNALES PHARMACEUTIQUES FRANCAISES, 2021, 79 (01): : 44 - 52